Physician

Andrew Baldwin Rose, M.D.

According to 2025 Medicare claims, Andrew Rose, M.D. (NPI: 1750591939) practices interventional cardiology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is CLINICAL SPECIALTY ASSOCIATES (NPI: 1760272538) and primary practice location at 19046-8001. Rose is affiliated with the Delaware Valley ACO (ACO ID: A2024), Community Care Collaborative of Pennsylvania and New Jersey LLC (ACO ID: A3318), and Doylestown Value Partners, LLC (ACO ID: A5245), participating under the MSSP model.

Rose's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 209 traditional Medicare patients, billed 578 HCPCS/CPT codes, and received $70,613 in Medicare payments. The top billing code was 93460 (Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist). Part D data shows 488 prescription claims across 96 beneficiaries totaling $107,678 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 37 records totaling $679. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $172,402 to $70,613. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $107,625 to $107,678. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	604	1,761	$172,402
2016	512	1,426	$188,729
2017	291	720	$137,595
2018	326	831	$182,212
2019	309	843	$171,994
2020	265	822	$122,281
2021	246	837	$117,027
2022	268	551	$81,851
2023	240	595	$92,117
2024	209	578	$70,613

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	2,457	$107,625
2016	230	2,162	$130,019
2017	122	500	$46,276
2018	26	92	$7,541
2019	40	170	$2,734
2020	28	180	$8,867
2021	61	359	$33,957
2022	65	284	$38,418
2023	88	367	$64,228
2024	96	488	$107,678

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93460	Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist	43	43	$266
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	61	62	$196
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	73	103	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	64	84	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	92	127	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	47	3,386	$63,744
Nexlizet	Bempedoic Acid/Ezetimibe	11	330	$4,327
Metoprolol Succinate	Metoprolol Succinate	83	7,374	$1,830
Clopidogrel	Clopidogrel Bisulfate	70	6,151	$1,005
Rosuvastatin Calcium	Rosuvastatin Calcium	32	2,880	$993

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$679	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Baldwin Rose, M.D.?

Tedicare shows public-source Medicare data for Andrew Baldwin Rose, M.D. (NPI 1750591939), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Baldwin Rose, M.D. have ACO affiliation data?

Andrew Baldwin Rose, M.D. is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024), Community Care Collaborative of Pennsylvania and New Jersey LLC (MSSP, ACO ID A3318), and Doylestown Value Partners, LLC (MSSP, ACO ID A5245).

What billing organization is linked to Andrew Baldwin Rose, M.D.?

Andrew Baldwin Rose, M.D. is linked to CLINICAL SPECIALTY ASSOCIATES (billing NPI 1760272538) in the available physician profile data.

Does Andrew Baldwin Rose, M.D. have Open Payments data?

Andrew Baldwin Rose, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.